Euphorbiasteroid is primarily studied for its anti-inflammatory and immunomodulatory properties. It has shown potential in inhibiting key inflammatory mediators such as nitric oxide and prostaglandin E2, making it a candidate for development in treating chronic inflammatory diseases. Research also indicates cytotoxic activity against certain cancer cell lines, suggesting possible use in oncology drug research. Additionally, it exhibits antioxidant effects, which may contribute to protective roles in degenerative conditions. Most applications remain in the preclinical research phase, with studies focused on understanding its mechanism and therapeutic potential.